**Trustees’ Annual Report for the period From 01/04/2024                   To  02/04/2025 Charity name: Crescent Kids Charity registration number: 1173388 Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|Summary of Objectives:<br>1.<br>Providing support, advice,<br>education and information<br>about sickle cell and<br>thalassaemia.<br>2.<br>Providing information and<br>raising awareness to<br>gradually decrease the<br>number of children born<br>with sickle cell and<br>thalassaemia.<br>3.<br>Providing grants and funds<br>towards studies to advance<br>health and find a cure for<br>Sickle Cell and thalassaemia.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and 1.19|During the period from 1 April<br>2024 to 2 April 2025, Crescent<br>Kids played a key role in<br>supporting a national research<br>project in collaboration with UCL<br>medical students and the UCL<br>Great Ormond Street Institute of<br>Child Health. The project,<br>commissioned by the National<br>Institute for Health and Care<br>Research, focused on<br>understanding the health and<br>education outcomes of children<br>living with sickle cell disease<br>across the UK. As part of this<br>work, we led engagement with<br>families and young people<br>through focus groups held in<br>London, Birmingham, and<br>Manchester. This activity<br>represented a significant portion<br>of our efforts during the year,<br>enabling us to gather valuable|






**----- Start of picture text -----**<br>
||||
|---|---|---|
|lived-experience insights to inform|
|the research and contribute to|
|improving outcomes for affected|
|children.|
|Statement confirming|Para 1.18|The trustees have ensured that|
|whether the trustees have|
|Crescent Kids’ work, including its|
|had regard to the guidance|
|issued by the Charity|support for research and|
|Commission on public|engagement with families of|
|benefit|children living with sickle cell|
|disease, is aligned with its|
|charitable objectives and provides|
|clear, tangible benefits to the|
|public. The trustees remain|
|committed to ensuring that all|
|activities contribute positively to|
|improving awareness, support,|
|and outcomes for affected|
|children and their families.|

**----- End of picture text -----**<br>


## **Additional information (optional)** 

You may choose to include further statements where relevant about: 


**----- Start of picture text -----**<br>
|||
|---|---|
|SORP reference|
|Policy on grant making|Para 1.38|
|Policy on social investment|Para 1.38|
|including program related|
|investment|
|Contribution made by|Para 1.38|
|volunteers|
|Other|
|Achievements and Performance|
|SORP reference|

**----- End of picture text -----**<br>


**Achievements and Performance** 



|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|During the year, Crescent Kids<br>made significant progress in<br>strengthening both its direct<br>support to families and its<br>contribution to wider systemic<br>change. A key achievement was<br>our involvement in a national<br>research project exploring the<br>health and education outcomes of<br>children living with sickle cell<br>disease, where we successfully<br>engaged families across London,<br>Birmingham, and Manchester to<br>share their lived experiences.<br>This work has helped ensure that<br>the voices of affected children<br>and their families are represented<br>in research that will inform future<br>policy and service improvements.<br>Alongside this, we continued to<br>provide practical and emotional<br>support to families, helping them<br>better navigate hospital care and<br>daily life with a chronic condition.<br>Collectively, our work has<br>contributed to raising awareness<br>of sickle cell disease, influencing<br>more inclusive and informed<br>approaches within healthcare and<br>education, and ultimately working<br>towards improved outcomes and<br>quality of life for children and their<br>families.|
|---|---|---|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Achievements against|Para 1.41|
|---|---|
|objectives set||
|Performance of fundraising|Para 1.41|
|activities against objectives||
|set||






**----- Start of picture text -----**<br>
||||
|---|---|---|
|Investment performance|Para 1.41|
|against objectives|
|Other|
|Financial Review|
|Statement explaining the|Para 1.22|The trustees have established a|
|policy for holding reserves|
|reserves policy to ensure the|
|stating why they are held|
|financial stability and continuity of|
|Crescent Kids’ activities. A level|
|of reserves is maintained to cover|
|essential operating costs in the|
|event that donations or funding|
|are temporarily reduced or|
|delayed. This approach enables|
|the charity to continue supporting|
|its initiatives and beneficiaries in|
|the short term without disruption.|
|Amount of reserves held|Para 1.22|£2,992.00|

**----- End of picture text -----**<br>


## **Financial Review** 

## **Additional information (optional)** 


**----- Start of picture text -----**<br>
|||
|---|---|
|You may choose to include further statements where relevant about:|
|The charity’s principal|Para 1.47|
|sources of funds (including|
|any fundraising)|
|Investment policy and|Para 1.46|
|objectives including any|
|social investment policy|
|adopted|
|A description of the principal|Para 1.46|
|risks facing the charity|
|Other|

**----- End of picture text -----**<br>


## **Structure, Governance and Management** 

Description of charity’s trusts: 



||Type of governing document|Para 1.25|CIO Constitution|
|---|---|---|---|
||(trust deed, royal charter)|||
||How is the charity|Para 1.25|CIO|
||constituted?|||
||(e.g unincorporated|||
||association, CIO)|||
|**Additional information (optional)**||||
|You maychoose to include further statements where relevant about:||||
||Policies and procedures|Para 1.51||
||adopted for the induction|||
||and training of trustees|||
||The charity’s organisational|Para 1.51||
||structure and any wider|||
||network with which the|||
||charity works|||
||Relationship with any related|Para 1.51||
||parties|||
||Other|||
|**Reference and Administrative details**||||
||Charity name|Crescent Kids||
||Other name the charity uses|N/A||
||Registered charity number|1173388||
||Charity’s principal address|8/12 Camden High Street, London, NW1 0JH||



**Names of the charity trustees who manage the charity** 

**Trustee name Office (if any) Dates acted if not for whole year Name of person (or body) entitled to appoint trustee (if any)** 

1 2 3 4 5 6 7 8 9 



10 11 12 13 14 15 16 17 18 19 20 

Corporate trustees – names of the directors at the date the report was approved 

Professor Alastair Mary Akinbiyi Tamsin Hunt Funmi Vanessa Ullam 


**----- Start of picture text -----**<br>
||||
|---|---|---|
|Additional information (optional)|
|Names and addresses of advisers (Optional information)|
|Type of|Name|Address|
|adviser|
|Name of chief executive or names of senior staff members (Optional information)|

**----- End of picture text -----**<br>


## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 



## **Other optional information** 

## **Declarations** 

**The trustees declare that they have approved the trustees’ report above. Signed on behalf of the charity’s trustees Signature(s)** Funmi V Ullam **Full name(s)** Funmi V Ullam **Position (eg Secretary, Chair, etc)** Trustee/Secretary **Date** 21.3.26 



||**Crescent Kids**|**Crescent Kids**|**Crescent Kids**|**Crescent Kids**|**Crescent Kids**|**1173388**|**1173388**||
|---|---|---|---|---|---|---|---|---|
||||||||||
||**Receipts andpayments accounts**||||||||
||**For the period**<br>**from**||1/4/24||**To**|2/4/25|||
||||||||||
|**Section A Receipts and payments**<br>**Unrestricted**<br>**funds**<br>**Restricted funds**<br>**Endowment**<br>**funds**<br>**Total funds**|||||||||
||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||
|Donation - Hairs CJ&DE|**5,000**||**-**||**-**||**5,000**||
|Donation - Aprons C Feeney|**200**||**-**||**-**||**200**||
|Donation - Manning|**100**||**-**||**-**||**100**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR) _|<br>**5,300**||**-**||**-**||**5,300**||
|~~——_—~~|~~——_—~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|
|**A2 Asset and investment sales,**<br>**(see table).**<br>~~——_—~~|~~——_—~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|
|~~——_—~~|**- 0**<br>~~——_—~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**-**<br>~~———~~|~~———~~|
|~~——_—~~|**- 0**<br>~~——_—~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**-**<br>~~———~~|~~———~~|
|**_Sub total_**<br>~~——_—~~|**_Sub total_**<br>**- 0**<br>~~——_—~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**-**<br>~~———~~|~~———~~|
|~~——_—~~|~~——_—~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|**5,300**<br>~~———~~|~~———~~|
|**_Total receipts_ **<br>~~——_—~~|<br>**5,300**<br>~~——_—~~|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**<br>~~———~~|~~———~~||~~———~~|
|~~——_—~~|~~——_—~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|~~———~~|
|**A3 Payments**|||||||||
||||**-**||**-**||**-**||
|Rent - 8/12 Camden High Street|**1,200**||**-**||**-**||**1,200**||
|Electricity - 8/12 Camden High Street|**318**||**-**||**-**||**318**||
|Focus Groups - CARES|**300**||**-**||**-**||**300**||
|Volunteers|**170**||**-**||**-**||**170**||
|Printing|**120**||**-**||**-**||**120**||
|Social Media|**200**||**-**||**-**||**200**||
||**- 0**||**-**||**-**||**-**||
||**- 0**||**-**||**-**||**-**||
|**_Sub total_ **|<br>**2,308**||**-**||**-**||**2,308**||
|~~———~~|~~———~~|~~———~~|||||||
|**A4 Asset and investment**<br>**purchases,(see table)**<br>~~———~~|~~———~~|~~———~~|||||||
|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**||**- 0**||**-**||
|~~———~~|**- 0**<br>~~———~~|~~———~~|**- 0**||**- 0**||**-**||
|**_Sub total_ **<br>~~———~~|<br>**- 0**<br>~~———~~|~~———~~|**- 0**||**- 0**||**-**||
|~~———~~|~~———~~|~~———~~|||||||
|**_Totalpayments_ **<br>~~———~~|<br>**2,308**<br>~~———~~|~~———~~|**- 0**||**- 0**||**2,308**||
|~~———~~<br>~~===>~~|~~———~~<br>~~===>~~|~~———~~<br>~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|
|**_Net of receipts/(payments)_ **<br>~~===>~~|<br>**2,992**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**2,992**<br>~~===>~~|~~===>~~|
|**A5 Transfers between funds**<br>~~===>~~|**- 0**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|
|**A6 Cash funds lastyear end**<br>~~===>~~|**- 0**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|
|**_Cash funds thisyear end_ **<br>~~===>~~|<br>**2,992**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**-**<br>~~===>~~|~~===>~~|**2,992**<br>~~===>~~|~~===>~~|
|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|~~===>~~|
|**Section B Statement of assets and liabilities at the end of the period**<br>**Categories**<br>**Details**<br>**Unrestricted**<br>**funds**<br>**Restricted funds**<br>~~a~~<br>~~ee~~|||||||||
|~~|~~|~~|~~|||~~|~~|**to nearest £**<br>~~|~~|~~|~~|**to nearest £**||
|**B1 Cash funds**<br>~~|~~|Cash<br>~~|~~|||~~|~~|**2,992**<br>~~|~~|~~|~~|**-**||
||~~|~~|||~~|~~|**-**<br>~~|~~|~~|~~|**-**||



21/03/2026 



||||||**-**||**-**||
|---|---|---|---|---|---|---|---|---|
||**_Total cash funds_**||||**2,992**||**-**||
||(agree balances with receipts and payments<br>account(s))||||OK||||
||||||**Unrestricted**<br>**funds**||**Restricted funds**||
||**Details**||||**to nearest £**||**to nearest £**||
|**B2 Other monetary assets**|||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B3 Investment assets**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||
|**B4 Assets retained for the**<br>**charity’s own use**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
||**Details**||||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||
|**B5 Liabilities**|||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||**-**||
||||||||||
|Signed by one or two trustees on behalf<br>of all the trustees|Signature<br>||||Print Name||||
||~~_Funmi Vanessa Ullam_~~||||Funmi Vanessa Ullam||||
||||||||||



CCXX R2 accounts (SS) 

21/03/2026 

2 



**CC16a Last year to the nearest £ - - - - - - - - - - 0 - 0 - 0 - - - - - - - - - - - 0 - 0 - - - - Endowment funds to nearest £ - -** 

CCXX R3 accounts (SS) 

21/03/2026 

3 



**-** OK **Endowment funds to nearest £ - - - - - - Current value (optional) - - - - - Current value (optional) - - - - - - - - - When due (optional)** 


## Date of approval 

21.3.26 

CCXX R4 accounts (SS) 

21/03/2026 

4 

